
News about Yantai
Stay current with all the latest and breaking news about Yantai, compare headlines and perspectives between news sources on stories happening today. In total, 18 stories have been published about Yantai which Ground News has aggregated in the past 3 months.
Local News Publishers
Suggest a source
Looking for a source we don't already have? Suggest one here.Top Yantai News

Yantai · Yantai**media[705674]****media[705675]**YANTAI, China, Aug. 8, 2025 /PRNewswire/ -- On August 8th, RemeGen Co., Ltd. (688331.SH/09995.HK) announces clearance of IND application by Food and Drug Administration (FDA) for phase II clinical trials for its independently-developed bispecific antibody, RC148, for the treatment of multiple advanced malignant solid tumors in the US. RC148 is a PD-1 and VEGF-targeting bispecific antibody, an innovative molecule…Read Article
RemeGen's Independently-Developed Bispecific Antibody RC148 Approved to Proceed Phase II Clinical Trial in US by FDA
100% Right coverage: 1 sources

Yantai · YantaiYANTAI, August 13, 2025 /PRNewswire/ — On August 13, Rongchang Biopharma (688331.SH/09995.HK) announced that its Phase III clinical study of tetasip, a world-first BLyS/APRIL dual-targeting fusion protein for the treatment of primary Sjögren's syndrome (pSS), achieved the primary endpoint as planned. Rongchang Biopharma will submit a marketing authorization application to the Center for Drug Evaluation (CDE) of the National Medical Products Admi…See the Story
Rongchang Biopharma's Phase Iii Clinical Study of Tetasip for the Treatment of Primary Sjögren's Syndrome Reached Its Primary Endpoint

Yantai · YantaiThe University of Queensland is leading the ‘Batteries at Sea and the Global SAR Community’ project with the IMRF and a range of other international partners, contributing to this research through discussions and sharing maritime search and rescue expertise.Read Article